Cargando…

Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy

Transthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of heart failure. Fortunately, the disease now has an approved therapy, with many others under development. Assessment of prognosis in ATTR-CM is critical to inform patients about the disease course and...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Kent Y., Loungani, Rahul S., Rao, Vishal N., Patel, Chetan B., Khouri, Michel G., Felker, G. Michael, DeVore, Adam D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352120/
https://www.ncbi.nlm.nih.gov/pubmed/34396189
http://dx.doi.org/10.1016/j.jaccao.2019.11.006